CEGEDIM |
Market Closed -
Other stock markets
|
Pre-market 02:13:31 am | |||
| 13.7 EUR | -1.08% |
|
13.72 | +0.18% |
| Mar. 28 | Cegedim: 23% increase in ROC in 2023 | CF |
| Mar. 27 | Transcript : Cegedim SA, 2023 Earnings Call, Mar 27, 2024 |
Business Summary
- Insurance companies and services (72.1%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS);
- Health care professionals (26.8%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.;
- other (1.1%).
France accounts for 89.7% of net sales.
Number of employees: 6,500
Sales per Business
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Software and Services
53.0
%
| 302 | 54.4 % | 327 | 53.0 % | +8.16% |
Data and Marketing
18.6
%
| 107 | 19.2 % | 115 | 18.6 % | +7.49% |
Flow
15.6
%
| 91 | 16.3 % | 96 | 15.6 % | +5.89% |
Business Process Outsourcing
11.6
%
| 53 | 9.5 % | 71 | 11.6 % | +34.94% |
Cloud & Support
1.2
%
| 3 | 0.5 % | 7 | 1.2 % | +154.03% |
Sales per region
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
France
89.7
%
| 497 | 89.5 % | 553 | 89.7 % | +11.24% |
United Kingdom
6.9
%
| 39 | 7.1 % | 43 | 6.9 % | +8.84% |
Euro Zone excluding France
2.1
%
| 12 | 2.1 % | 13 | 2.1 % | +10.56% |
Rest of the World
1.2
%
| 7 | 1.3 % | 8 | 1.2 % | +3.36% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 81 | 69-08-26 | |
| Director of Finance/CFO | - | 16-06-13 | |
Laurent Labrune
BRD | Director/Board Member | 53 | 94-12-31 |
| Director/Board Member | 70 | 83-12-31 | |
Christelle Vivet
LAW | General Counsel | - | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 81 | 69-08-26 | |
Marcel Kahn
BRD | Director/Board Member | 67 | 16-06-13 |
| Director/Board Member | 70 | 83-12-31 | |
Laurent Labrune
BRD | Director/Board Member | 53 | 94-12-31 |
| Director/Board Member | 50 | 98-12-31 | |
| Director of Finance/CFO | - | 16-06-13 | |
| Director/Board Member | - | 10-01-07 | |
| Director/Board Member | 64 | 18-12-31 | |
Catherine Abiven
BRD | Director/Board Member | 57 | 19-08-29 |
Béatrice Saunier
BRD | Director/Board Member | - | 18-08-30 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 13,997,173 | 6,076,083 ( 43.41 %) | 419,618 ( 2.998 %) | 43.41 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
CEGEDIM 2.57% | 359,991 | 2.57% | 5,054,274 $ |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
CETIP SA
 CETIP SA Medical/Nursing ServicesHealth Services Cetip SA provides third party healthcare management services. It guarantees access to fee waivers in many segments of the healthcare offer and allows you to manage services such as co-payments or more complex services including fixed-price and annualized. The firm uses a third-party online payment system. The company was founded on January 1, 1996 and is headquartered in Boulogne-Billancourt, France. |
Medical/Nursing Services
|
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
13.7
EUR
Average target price
20.7
EUR
Spread / Average Target
+51.09%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.29% | 199M | |
| +8.63% | 315B | |
| +19.09% | 205B | |
| +2.19% | 148B | |
| +12.06% | 56.83B | |
| +9.04% | 32.08B | |
| -1.15% | 28.6B | |
| +109.62% | 23.35B | |
| +21.04% | 18.99B | |
| -2.39% | 14.12B |
- Stock Market
- Equities
- CGM Stock
- Company Cegedim
